WOBURN, MA, Spear Bio, a biotechnology company enabling the measurement of protein molecules, announced the closing of its $45 million Series A financing.
Spear Bio Inc., a biotechnology company enabling the measurement of protein molecules down to dozens of copies with ubiquitous qPCR equipment, announced the successful closing of its $45 million Series A financing. The oversubscribed round was co-led by Foresite Capital and Bio-Techne Corporation, with additional participation from existing investors including Maverick Ventures, Yonjin Capital and CDH Investments.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
